Skip to content

Anxiety: all studies

Page 702 of 772: studies 7,011 to 7,020 of 7,715, newest first. Back to the anxiety overview

Research

Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristics.

Neuropsychobiology 2015 Giuseppe Plazzi, Chiara Fabbri, Fabio Pizza et al.

The occurrence of psychotic symptoms in narcolepsy type 1 (NT1) has been reported as responsible for delayed diagnosis due to the misdiagnosis of schizophrenia. This study aimed to identify shared and distinctive clinical characteristics between NT1 and schizophrenia, with the focus on psychotic symptoms. A total of 28 NT1 and 21 schizophrenia patients were included. Hallucination...

Study protocol of a multicenter randomized controlled trial comparing the effectiveness of group and individual internet-based Mindfulness-Based Cognitive Therapy with treatment as usual in reducing psychological distress in cancer patients: the BeMind study.

BMC Psychology 2015 Felix R. Compen, Else Bisseling, Marije L. van der Lee et al.

Mindfulness-based interventions have shown to reduce psychological distress in cancer patients. The accessibility of mindfulness-based interventions for cancer patients could be further improved by providing mindfulness using an individual internet-based format. The aim of this study is to test the effectiveness of a Mindfulness-Based Cognitive Therapy (MBCT) group intervention for cancer...

Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice.

PLoS One 2015 Emily M Johansson, María S García-Gutiérrez, Maria Moscoso‐castro et al.

The recreational drugs, alcohol and 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") have both been shown to cause immune activation in vivo, and they are linked to cognitive impairment and anxiety-like behaviors in rodents. The neuronal effects of these drugs in the hippocampal area, an area that has been a focus of studies aiming to explain the mechanisms underlying anxiety...

N,N-Dimethyltryptamine-Induced Psychosis.

Clinical Neuropharmacology 2015 Neil E Paterson, W Connor Darby, Preetpal S Sandhu

N,N-dimethyltryptamine (DMT) is a 5-hydroxytryptamine 2A and 1A receptor agonist that exhibits potent psychoactive properties in humans. Recreational use of this drug has increased precipitously and is likely to result in an increase in patients presenting with substance-induced psychoses. The present case provides an early example of substance-induced psychosis attributable to repeated use of...

The neural and psychological mechanisms of yoga and mindfulness meditation

2015 Tim Gard 2 citations

Pain can be modulated by several cognitive techniques, typically involving increased cognitive control and decreased sensory processing. Recently, it has been demonstrated that pain can also be attenuated by mindfulness. Here we investigate the underlying brain mechanisms by which the state of mindfulness reduces pain. Mindfulness practitioners and controls received unpleasant electric stimuli...

DOI: 10.26481/dis.20150320tg (opens in new tab) Full text (opens in new tab) Cognition Mindfulness meditation Mechanism biology Psychotherapist +3

Treating your worst nightmare: a case-series of imagery rehearsal therapy for nightmares in individuals experiencing psychotic symptoms

The Cognitive Behaviour Therapist 2015 Bryony Sheaves, Juliana Onwumere, Nadine Keen et al.

AbstractPrevious research has indicated that nightmares might be a common problem for people with psychotic symptoms. Furthermore, more distressing nightmares have been associated with higher levels of delusional severity, depression, anxiety, stress and working memory. However no known research has investigated the use of nightmare treatments in those with symptoms of psychosis. This study...

Dream Therapy for PTSD

2015 Bruce M. Dow

In this series of clinical vignettes, a board-certified psychiatrist and life fellow of the American Psychiatric Association illustrates the effectiveness of dream therapy in treating posttraumatic stress disorder (PTSD). Posttraumatic stress disorder (PTSD) can be disabling and difficult to treat, often leading to depression, suicide, and homicide in extreme cases. In this clinical-based...

Smoke your troubles away: exploring the effects of death cognitions on cannabis craving and consumption.

Journal of Psychoactive Drugs 2015 Maayan Nagar, Sharon Rabinovitz

Two studies informed by the terror management health model were conducted to examine the question of how death cognition affects cannabis craving and whether actual cannabis smoking alleviates death cognitions. The first study examined whether priming thoughts of death are associated with subjective cannabis craving among 42 frequent cannabis users randomly assigned to either a mortality...

Travails of the terminally ill and dying with cancer

Journal of Cancer Research and Therapeutics 2015 Nagraj Huilgol 1 citation

In a big yawn of death life is extinguished, ennui of existence comes to an end. The implacable pain evokes a cascade of emotions so does the idea of death and dying. Pain is not always somatic, but would also signify loss of dignity, incontinence, disfigurement, cognitive impairment, nutritional deprivation and immobility. Palliative care is a neglected aspect of cancer care. There are just a...

DOI: 10.4103/0973-1482.159980 (opens in new tab) Dignity Terminally ill Palliative care Delirium +6

Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat

The International Journal of Neuropsychopharmacology December 28, 2014 Stephanie M. Gorka, Daniel A. Fitzgerald, Harriet de Wit et al. 43 citations

BACKGROUND: Δ(9)-Tetrahydrocannabinol has been shown to modulate anxiety and facilitate the extinction of fear by inhibiting amygdala reactivity. Since functional coupling between the amygdala and prefrontal cortex is implicated in affective processes, it is possible that Δ(9)-tetrahydrocannabinol affects amygdala-prefrontal cortex functional connectivity in ways that differ across amygdala...

DOI: 10.1093/ijnp/pyu104 (opens in new tab) Full text (opens in new tab) Tetrahydrocannabinol Basolateral amygdala Ventromedial prefrontal cortex Anterior cingulate cortex +3